Related Experiment Video
Updated: Mar 22, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Assessment of vascular function in systemic onset juvenile idiopathic arthritis
Betul Sozeri1, Basak Yildiz Atikan2, Kadriye Ozdemir3
1Department of Pediatric Rheumatology, Ege University Faculty of Medicine, Izmir, Turkey. betulsozeri@yahoo.com.
Insights
Children with systemic juvenile idiopathic arthritis (sJIA) show early signs of vascular dysfunction and arterial stiffness. This impairment is linked to disease duration and corticosteroid therapy, highlighting the need for cardiovascular monitoring in pediatric rheumatic diseases.
Area of Science:
- Pediatric Rheumatology
- Cardiovascular Health
- Vascular Biology
Background:
- Rheumatic disorders, including systemic juvenile idiopathic arthritis (sJIA), are associated with an increased incidence of cardiovascular disease.
- Chronic inflammation in sJIA can lead to early-onset atherosclerosis in pediatric patients.
- Early detection of vascular dysfunction is crucial for managing long-term cardiovascular risk in children with sJIA.
Purpose of the Study:
- To assess early vascular dysfunction in children diagnosed with sJIA.
- To investigate the influence of sJIA therapy on vascular health.
- To identify correlations between disease characteristics and vascular parameters.
Main Methods:
- Carotid-femoral pulse wave velocity (PWV) and augmentation index (AIx) were measured using a Vicorder to evaluate arterial stiffness.
- Thirty-three sJIA patients were compared to 72 age- and sex-matched healthy controls, all without obesity or cardiovascular risk factors.
- Statistical analysis was performed to correlate vascular parameters with disease duration, activity, and therapeutic interventions.
Main Results:
- Patients with sJIA exhibited significantly higher levels of PWV and AIx compared to controls, indicating impaired vascular function.
- A positive correlation was found between PWV and disease duration (p=0.003).
- Corticosteroid therapy was associated with increased PWV (p<0.05), while non-steroid therapies (methotrexate, anti-TNF alfa agents) showed no significant association with vascular parameters.
Conclusions:
- Vascular function is impaired in young patients with sJIA, even in the absence of traditional cardiovascular risk factors.
- Disease-related factors, including inflammation, disease activity, and corticosteroid treatment, contribute to vascular dysfunction in sJIA.
- These findings underscore the importance of early cardiovascular risk assessment and management in children with sJIA.
Abstract:
An increased incidence of cardiovascular disease has been found in rheumatic disorders. Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children. Prolonged immunological inflammatory process leads these patients to an early onset of atherosclerosis. We aimed to assess the presence of early vascular dysfunction in patients with systemic onset juvenile idiopathic arthritis (sJIA) and investigate the role of therapy sJIA in vascular health. Thirty-three patients (22 males, 11 females) diagnosed with sJIA according to the International League of Associations for Rheumatology criteria were compared to 72 age- and sex-matched controls. None of the participants was overweight, obese, or had a history of hypertension, dyslipidemia, diabetes mellitus, or cardiovascular disease. Arterial stiffness (As) was evaluated by measurement of carotid-femoral pulse wave velocity (PWV) and augmentation index (AIx) with a Vicorder. The mean age of patients in this study was 9.96 ± 3.71 years (range 4-16 years) and the mean age of controls was 10.9 ± 3.52 years (range 4-19 years). These two groups were well matched for age, sex, and BMI. The mean age of patients at the onset of disease was 7.06 ± 3.9 years (range 3-15 years). The mean duration of disease and active disease was 79 ± 45 months (range 6-162 months) and 58 ± 49 months (range 1-101 months), respectively. The highest levels of PWV and AIx were found in the patient group. Seven patients had had macrophage activation syndrome at presentation. In these patients, vascular changes were higher than other patients (6.30 ± 0.42 m/s vs 5.17 ± 0.55 m/s, p = 0.01, respectively). The corticosteroid therapy was found associated with higher PWV, (p < 0.05), while there was no difference between vascular parameters and use of non-steroid therapies (methotrexate (MTX), anti-TNF alfa agents). We also find statistically significant correlation between PWV and disease duration (p = 0.003, r = 0.45). Vascular function is impaired in patients with sJIA at a very young age. Vascular dysfunction may be partly attributed to the effects of disease-related characteristics (inflammation, disease activity, and medications).
Related Concept Videos
Vascular Spasm
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Overview of Systemic Arteries
Systemic circulation is the part of the cardiovascular system that carries oxygenated blood away from the heart to the body's tissues and returns deoxygenated blood back to the...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Arteries of Lower Limbs

